$GILD News Cypress, Spansion shares rally on m
Post# of 102480
Posted On: 12/06/2014 11:33:02 AM
$GILD News
Cypress, Spansion shares rally on merger plan 5:36 p.m. Dec. 1, 2014 - MarketWatch
Mylan to manufacture, distribute Gilead Sciences HIV drug 7:49 a.m. Dec. 1, 2014 - Angela Chen
10 stocks that may revisit their highs as the year ends 10:30 a.m. Nov. 24, 2014 - Philip van Doorn
Are consumers getting gouged on health care? 9:35 a.m. Nov. 22, 2014 - Russ Britt
Gilead Sciences shares slide 1.7% 9:35 a.m. Nov. 19, 2014 - Sue Chang
The double-edged sword of growth-stock speculation 2:29 p.m. Nov. 14, 2014 - The Trading Deck
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers 9:31 a.m. Nov. 10, 2014 - Sue Chang
Visa shares rise after hours on earnings beat 6:50 p.m. Oct. 29, 2014 - Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing 8:34 a.m. Oct. 29, 2014 - Shawn Langlois
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
Sales of Gilead's pricey hepatitis C drug slow 4:26 p.m. Oct. 28, 2014 - MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss 4:14 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results 4:09 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln 4:08 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:22 p.m. Dec. 5, 2014 - TheStreet.com
Why Gilead Is A Better Buy Than AbbVie 2:52 p.m. Dec. 5, 2014 - Seeking Alpha
Cramer Says It May Finally Be Time to Buy Laggard Gilead Sciences 12:18 p.m. Dec. 5, 2014 - TheStreet.com
Gilead Sciences Spikes Higher As Barron's Suggests Looking Beyond Hepatitis-C 9:50 a.m. Dec. 5, 2014 - benzinga.com
'Mad Money' Lightning Round: Buy, Buy, Buy Texas Instruments 6:00 a.m. Dec. 5, 2014 - TheStreet.com
Cramer's Lightning Round - Constellation Brands Has Real Magic (12/4/14) 4:36 a.m. Dec. 5, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Google Is Better Than the Market Thinks 8:31 p.m. Dec. 4, 2014 - TheStreet.com
Hot Drugmakers Build More Labs, Grab Space In Boston 3:47 p.m. Dec. 4, 2014 - Investors Business Daily
Gilead Sciences: An Alpha Stock Through The Good And Bad Times 3:14 p.m. Dec. 4, 2014 - Seeking Alpha
A Practical Approach To Tech Investing 9:00 a.m. Dec. 4, 2014 - Seeking Alpha
U.S. Veterans get Sovaldi for $594/pill 8:43 a.m. Dec. 4, 2014 - Seeking Alpha
Cramer's Mad Money - PVH Fits Well At A Discount (12/3/14) 6:04 a.m. Dec. 4, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Cyclical Stocks Are Fund Manager Picks Now 8:36 p.m. Dec. 3, 2014 - TheStreet.com
Third Quarter Earnings Season In Review: Sector Winners And Losers, The Misleading 'Record' Beat Rate And The Outlook For Q4 5:50 p.m. Dec. 3, 2014 - Seeking Alpha
Actelion submits MAA for pulmonary hypertension drug 3:36 p.m. Dec. 3, 2014 - Seeking Alpha
Gilead Sciences' (GILD) Management Presents at Piper Jaffray Healthcare Conference (Transcript) 11:53 a.m. Dec. 3, 2014 - Seeking Alpha
Mylan, Gilead Ink Deal for TAF-based HIV Drugs - Analyst Blog 5:45 p.m. Dec. 2, 2014 - Zacks.com
Apple, Facebook: Jason Weiner Of Fidelity's View 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
An Update For Gilead Sciences 4:32 p.m. Dec. 2, 2014 - Seeking Alpha
Gilead Set To Trounce AbbVie's HCV Combo 11:29 a.m. Dec. 2, 2014 - Seeking Alpha
Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power 8:45 a.m. Dec. 4, 2014 - PR Newswire - PRF
Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries 7:00 a.m. Dec. 1, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Apple, Alibaba, Hewlett-Packard, Gilead Sciences, Petrobras, and BlackBerry 8:45 a.m. Nov. 26, 2014 - PR Newswire - PRF
Critical Alerts For SouFun, Petroleo Brasileiro, Gilead Sciences, Transocean and iRobot Released By InvestorsObserver 9:31 a.m. Nov. 24, 2014 - PR Newswire - PRF
Earnings Forecast Research for Kinder Morgan, Petrobras, Freeport-McMoRan, Keurig Green Mountain, Gilead Sciences, and Alibaba 8:45 a.m. Nov. 24, 2014 - PR Newswire - PRF
Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power 8:45 a.m. Nov. 20, 2014 - PR Newswire - PRF
Knight Sells Priority Review Voucher to Gilead 5:11 p.m. Nov. 19, 2014 - Marketwired
European Commission Grants Marketing Authorization for Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4 10:07 a.m. Nov. 18, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba 8:45 a.m. Nov. 18, 2014 - PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com 8:45 a.m. Nov. 14, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 5:59 p.m. Nov. 12, 2014 - BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper 8:45 a.m. Nov. 12, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power 8:45 a.m. Nov. 10, 2014 - PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014 10:56 a.m. Nov. 7, 2014 - Marketwired
Linkage Biosciences Adds to Board Leadership 8:02 a.m. Nov. 7, 2014 - Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Nov. 6, 2014 - PR Newswire - PRF
Cypress, Spansion shares rally on merger plan 5:36 p.m. Dec. 1, 2014 - MarketWatch
Mylan to manufacture, distribute Gilead Sciences HIV drug 7:49 a.m. Dec. 1, 2014 - Angela Chen
10 stocks that may revisit their highs as the year ends 10:30 a.m. Nov. 24, 2014 - Philip van Doorn
Are consumers getting gouged on health care? 9:35 a.m. Nov. 22, 2014 - Russ Britt
Gilead Sciences shares slide 1.7% 9:35 a.m. Nov. 19, 2014 - Sue Chang
The double-edged sword of growth-stock speculation 2:29 p.m. Nov. 14, 2014 - The Trading Deck
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers 9:31 a.m. Nov. 10, 2014 - Sue Chang
Visa shares rise after hours on earnings beat 6:50 p.m. Oct. 29, 2014 - Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing 8:34 a.m. Oct. 29, 2014 - Shawn Langlois
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
Sales of Gilead's pricey hepatitis C drug slow 4:26 p.m. Oct. 28, 2014 - MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss 4:14 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results 4:09 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln 4:08 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:22 p.m. Dec. 5, 2014 - TheStreet.com
Why Gilead Is A Better Buy Than AbbVie 2:52 p.m. Dec. 5, 2014 - Seeking Alpha
Cramer Says It May Finally Be Time to Buy Laggard Gilead Sciences 12:18 p.m. Dec. 5, 2014 - TheStreet.com
Gilead Sciences Spikes Higher As Barron's Suggests Looking Beyond Hepatitis-C 9:50 a.m. Dec. 5, 2014 - benzinga.com
'Mad Money' Lightning Round: Buy, Buy, Buy Texas Instruments 6:00 a.m. Dec. 5, 2014 - TheStreet.com
Cramer's Lightning Round - Constellation Brands Has Real Magic (12/4/14) 4:36 a.m. Dec. 5, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Google Is Better Than the Market Thinks 8:31 p.m. Dec. 4, 2014 - TheStreet.com
Hot Drugmakers Build More Labs, Grab Space In Boston 3:47 p.m. Dec. 4, 2014 - Investors Business Daily
Gilead Sciences: An Alpha Stock Through The Good And Bad Times 3:14 p.m. Dec. 4, 2014 - Seeking Alpha
A Practical Approach To Tech Investing 9:00 a.m. Dec. 4, 2014 - Seeking Alpha
U.S. Veterans get Sovaldi for $594/pill 8:43 a.m. Dec. 4, 2014 - Seeking Alpha
Cramer's Mad Money - PVH Fits Well At A Discount (12/3/14) 6:04 a.m. Dec. 4, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Cyclical Stocks Are Fund Manager Picks Now 8:36 p.m. Dec. 3, 2014 - TheStreet.com
Third Quarter Earnings Season In Review: Sector Winners And Losers, The Misleading 'Record' Beat Rate And The Outlook For Q4 5:50 p.m. Dec. 3, 2014 - Seeking Alpha
Actelion submits MAA for pulmonary hypertension drug 3:36 p.m. Dec. 3, 2014 - Seeking Alpha
Gilead Sciences' (GILD) Management Presents at Piper Jaffray Healthcare Conference (Transcript) 11:53 a.m. Dec. 3, 2014 - Seeking Alpha
Mylan, Gilead Ink Deal for TAF-based HIV Drugs - Analyst Blog 5:45 p.m. Dec. 2, 2014 - Zacks.com
Apple, Facebook: Jason Weiner Of Fidelity's View 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
An Update For Gilead Sciences 4:32 p.m. Dec. 2, 2014 - Seeking Alpha
Gilead Set To Trounce AbbVie's HCV Combo 11:29 a.m. Dec. 2, 2014 - Seeking Alpha
Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power 8:45 a.m. Dec. 4, 2014 - PR Newswire - PRF
Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries 7:00 a.m. Dec. 1, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Apple, Alibaba, Hewlett-Packard, Gilead Sciences, Petrobras, and BlackBerry 8:45 a.m. Nov. 26, 2014 - PR Newswire - PRF
Critical Alerts For SouFun, Petroleo Brasileiro, Gilead Sciences, Transocean and iRobot Released By InvestorsObserver 9:31 a.m. Nov. 24, 2014 - PR Newswire - PRF
Earnings Forecast Research for Kinder Morgan, Petrobras, Freeport-McMoRan, Keurig Green Mountain, Gilead Sciences, and Alibaba 8:45 a.m. Nov. 24, 2014 - PR Newswire - PRF
Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power 8:45 a.m. Nov. 20, 2014 - PR Newswire - PRF
Knight Sells Priority Review Voucher to Gilead 5:11 p.m. Nov. 19, 2014 - Marketwired
European Commission Grants Marketing Authorization for Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4 10:07 a.m. Nov. 18, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba 8:45 a.m. Nov. 18, 2014 - PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com 8:45 a.m. Nov. 14, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 5:59 p.m. Nov. 12, 2014 - BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper 8:45 a.m. Nov. 12, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power 8:45 a.m. Nov. 10, 2014 - PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014 10:56 a.m. Nov. 7, 2014 - Marketwired
Linkage Biosciences Adds to Board Leadership 8:02 a.m. Nov. 7, 2014 - Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Nov. 6, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼